Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.

Apperson ML, Tian Y, Stamova B, Ander BP, Jickling GC, Agius MA, Sharp FR.

J Neuroimmunol. 2013 Apr 15;257(1-2):90-6. doi: 10.1016/j.jneuroim.2013.02.004. Epub 2013 Mar 9.

PMID:
23477965
2.

Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations.

Alcina A, Abad-Grau Mdel M, Fedetz M, Izquierdo G, Lucas M, Fernández O, Ndagire D, Catalá-Rabasa A, Ruiz A, Gayán J, Delgado C, Arnal C, Matesanz F.

PLoS One. 2012;7(1):e29819. doi: 10.1371/journal.pone.0029819. Epub 2012 Jan 13.

3.

Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals.

Agliardi C, Guerini FR, Saresella M, Caputo D, Leone MA, Zanzottera M, Bolognesi E, Marventano I, Barizzone N, Fasano ME, Al-Daghri N, Clerici M.

Brain Behav Immun. 2011 Oct;25(7):1460-7. doi: 10.1016/j.bbi.2011.05.015. Epub 2011 Jun 12.

PMID:
21664963
4.

Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.

Abolfazli R, Samadzadeh S, Sabokbar T, Siroos B, Armaki SA, Aslanbeiki B, Ghelman M, Taheri T, Shakoori A.

J Neurol Sci. 2014 Oct 15;345(1-2):92-6. doi: 10.1016/j.jns.2014.07.013. Epub 2014 Jul 16.

PMID:
25064442
5.

The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis.

Kollaee A, Ghaffarpor M, Ghlichnia HA, Ghaffari SH, Zamani M.

Int J Immunogenet. 2012 Oct;39(5):414-22. doi: 10.1111/j.1744-313X.2012.01104.x. Epub 2012 Mar 9.

PMID:
22404765
6.

HLA-DRB1*15:01 and multiple sclerosis: a female association?

Irizar H, Muñoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Triviño T, Prada A, Saenz-Cuesta M, De Juan D, Lopez de Munain A, Olascoaga J, Otaegui D.

Mult Scler. 2012 May;18(5):569-77. doi: 10.1177/1352458511426813. Epub 2011 Nov 29.

PMID:
22127897
7.

Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.

Nolan D, Castley A, Tschochner M, James I, Qiu W, Sayer D, Christiansen FT, Witt C, Mastaglia F, Carroll W, Kermode A.

Neurology. 2012 Aug 7;79(6):538-46. doi: 10.1212/WNL.0b013e318263c407. Epub 2012 Jul 11.

PMID:
22786591
8.

Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.

Shahbazi M, Roshandel D, Omidnyia E, Rshaidbaghan A.

Clin Immunol. 2011 Jun;139(3):277-81. doi: 10.1016/j.clim.2011.02.012. Epub 2011 Feb 12.

PMID:
21396892
9.

Frequency of HLA-DRB1 gene alleles in patients with multiple sclerosis in a Lithuanian population.

Balnytė R, Rastenytė D, Mickevičienė D, Vaitkus A, Skrodenienė E, Vitkauskienė A.

Medicina (Kaunas). 2012;48(1):9-14. Epub 2012 Feb 22.

10.

Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort.

Romero-Pinel L, Martínez-Yélamos S, Bau L, Matas E, Gubieras L, María Pujal J, Morandeira F, Bas J, Arbizu T.

Eur J Neurol. 2011 Oct;18(10):1258-62. doi: 10.1111/j.1468-1331.2011.03379.x. Epub 2011 Mar 21.

PMID:
21418440
11.

HLA associations with multiple sclerosis in Greece.

Kouri I, Papakonstantinou S, Bempes V, Vasiliadis HS, Kyritsis AP, Pelidou SH.

J Neurol Sci. 2011 Sep 15;308(1-2):28-31. doi: 10.1016/j.jns.2011.06.037. Epub 2011 Jul 8.

PMID:
21741664
12.

Association between Parkinson's disease and the HLA-DRB1 locus.

Ahmed I, Tamouza R, Delord M, Krishnamoorthy R, Tzourio C, Mulot C, Nacfer M, Lambert JC, Beaune P, Laurent-Puig P, Loriot MA, Charron D, Elbaz A.

Mov Disord. 2012 Aug;27(9):1104-10. doi: 10.1002/mds.25035. Epub 2012 Jul 13.

PMID:
22807207
13.

Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.

Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH; International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF.

PLoS One. 2013;8(3):e58352. doi: 10.1371/journal.pone.0058352. Epub 2013 Mar 5.

14.

ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501.

Wagner M, Wiśniewski A, Bilińska M, Pokryszko-Dragan A, Nowak I, Kuśnierczyk P, Jasek M.

J Neuroimmunol. 2013 May 15;258(1-2):71-6. doi: 10.1016/j.jneuroim.2013.02.015. Epub 2013 Mar 16.

PMID:
23507476
15.

The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.

Ghlichnia HA, Kollaee A, Gaffarpoor M, Movafagh A, Ghlichnia B, Zamani M.

Acta Med Iran. 2014;52(6):418-23.

16.

Association of HLA-DRB1*15:02 and DRB5*01:02 allele with the susceptibility to systemic sclerosis in Thai patients.

Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Ohnogi Y, Nakaue N, Kuwata S, Takeuchi F.

Rheumatol Int. 2013 Aug;33(8):2069-77. doi: 10.1007/s00296-013-2686-3. Epub 2013 Feb 13.

PMID:
23404077
17.

HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Fernández O, R-Antigüedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, Guerrero M, Papais-Alvarenga M, Fernández-Sánchez V, Leyva L.

J Neurol. 2009 Dec;256(12):1977-88. doi: 10.1007/s00415-009-5223-2.

PMID:
19585166
18.

The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.

Tuwir I, Dunne C, Crowley J, Saddik T, Murphy R, Cassidy L.

Br J Ophthalmol. 2007 Oct;91(10):1288-92.

19.

Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations.

Wu XM, Wang C, Zhang KN, Lin AY, Kira J, Hu GZ, Qu XH, Xiong YQ, Cao WF, Gong LY.

Mult Scler. 2009 Dec;15(12):1422-30. doi: 10.1177/1352458509345905. Epub 2009 Nov 13.

PMID:
19965521
20.

No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.

Handel AE, De Luca GC, Morahan J, Handunnetthi L, Sadovnick AD, Ebers GC, Ramagopalan SV.

J Neuroimmunol. 2010 Jun;223(1-2):120-3. doi: 10.1016/j.jneuroim.2010.03.002. Epub 2010 Apr 14.

PMID:
20394989

Supplemental Content

Support Center